Quantum medicine and regenerative medicine represent transformative frontiers in healthcare. This article explores their possible unification, by emphasizing Tesla waves (scalar waves) and 528 Hz sound frequency as potential bridges to enhance regenerative processes. By integrating quantum principles with regenerative therapies, this innovative approach has the potential to optimize cellular energy, accelerate recovery, and offer non-invasive treatment protocols. Rigorous scientific study is critical to substantiate these approaches and unlock their potential.
Dr. Aimee Duffy, MD, is a board-certified physician and founder of Carolina Integrative
Medicine, specializing in integrative healthcare for women. A bestselling author of "Normal
Doesn’t Have Side Effects", Dr. Duffy combines her extensive knowledge of conventional
medicine with holistic treatments to create personalized care plans that include nutrition, lifestyle
adjustments, and hormone balancing.
Dr. Pamela Wartian Smith, M.D., MPH, MS, a renowned expert in hormone health, will present
on key topics including endocrine disruptors, women’s hormones, and hypothyroidism. She will
explore how environmental chemicals—such as BPA from plastics—disrupt hormone balance,
impacting the hypothalamic-pituitary-gonadal axis and pituitary-adrenal function.
Dr. Shimek is a Functional Medicine Practitioner and Naturopathic Physician celebrated for her expertise in women’s health, biohacking, and epigenetics.
Dr. Brownstein will be presenting at the 2025 Annual Restorative Medicine Conference on the topic of A Holistic Approach to Autoimmune Thyroid.
This case study reports on the novel combination of three treatments for cognitive decline in a 79-year-old male: therapeutic plasma exchange (TPE), peptides, and human umbilical cord tissue mesenchymal stem cells and exosomes (UCT-MSC-EXs).
To our knowledge, this is the first case study to report on reducing biological age, increasing telomere length, and improving cognition using this unique combination of therapies in a patient with mild to moderate cognitive decline.
The prevalence of organ-specific and systemic autoimmune conditions is increasing worldwide. Certain phytoconstituents may be helpful as part of a therapeutic protocol for autoimmune rheumatic conditions, as they have been shown to have immunoregulatory effects in experimental and pre-clinical studies.
A combination of genetic, epigenetic, and environmental factors is thought to contribute to the development of rheumatoid arthritis.
The need for safe and effective therapies to promote cognitive health, and the growing interest in healthy longevity have brought the therapeutic promise of neuropeptides increasingly to the forefront of restorative medicine practice.
This case study reports on the novel combination of three treatments for cognitive decline in a 79-year-old male: therapeutic plasma exchange (TPE), peptides, and human umbilical cord tissue mesenchymal stem cells and exosomes (UCT-MSC-EXs).
To our knowledge, this is the first case study to report on reducing biological age, increasing telomere length, and improving cognition using this unique combination of therapies in a patient with mild to moderate cognitive decline.
A growing body of evidence shows that susceptibility to adult-onset CVD begins in early life, even in utero, presumably as a result of epigenetic dysregulation.
A growing body of evidence shows that susceptibility to adult-onset CVD begins in early life, even in utero, presumably as a result of epigenetic dysregulation.
